Celestial Biolabs (Delisted) share news and announcements

BSE: 532871Pharmaceuticals & Biotechnology

Formerly Celestial Labs

Last traded ₹1.75 on 11 Mar 2020

Delisted on 16 Oct 2024.

Celestial Biolabs share news and announcements

634 announcements, routine notices left out, newest first. Page 11 of 13.

  1. Jun 2012

  2. May 2012

  3. Apr 2012

  4. Mar 2012

    • 9 Mar · Address Change

      Registered office of the Company has been shifted from Plot # 231A, MLA Colony, Road # 12, Banajara Hills, Hyderabad- 500034 to Plot No. 59, Road No. 12, APIIC Tech Park, IDA Nacharam, Hyderabad - 500076 with effect from March 01, 2012, as per the resolution passed by the Board of Directors.
    • 6 Mar · Shifting of the Registered Office of the Company

      Registered office of the Company has been shifted from Plot # 231A, MLA Colony, Road # 12, Banjara Hills, Hyderabad- 500034 to Plot No. 59, ....
  5. Feb 2012

  6. Jan 2012

    • 25 Jan · Board meeting

      Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on February 03, 2012 to consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2011.
  7. Nov 2011

  8. Sep 2011

  9. Aug 2011

    • 8 Aug · Board meeting

      Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on August 12, 2011 to consider the following : (1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2011; and (2) To consider the audited financial results for the Financial year ended March 31, 2011.
  10. May 2011

  11. Apr 2011

    • 29 Apr · Meeting

      Members at the Extra Ordinary General Meeting (EGM) of the Company held on April 28, 2011, inter alia, have passed the following resolutions: ....
    • 8 Apr · Board meeting

      Board of Directors of the Company at its meeting held on April 05, 2011, inter alia, has transacted the following: 1. Dr. A. N. Singh ....
    • 8 Apr · Board meeting

      Outcome of the meeting of the Board of Directors is as follows : (1) Dr. A. N. Singh has proposed, subject to all necessary approvals, to renounce his entitlement of Sweat Equity Shares for the balance consideration amount of Rs.4.91 crores (towards the transfer of IPRs developed and owned by him to the Company) which is 60% (approx) of his total entitlement of Rs.8.17 crores; (2) To convene an Extraordinary General Meeting of the Company on April 28, 2011 to consider the following : (a) To obtain the consent of the shareholders, subject to necessary approvals, if any, from various regulatory agencies, for allotment of the Equity Shares of the Company, renounced by Dr. A. N. Singh, the Promoter of the Company to the shareholders (other than Promoter Group) and the employees of the company, without any consideration, (b) To fill the casual vacancy caused in the office of the statutory auditor of the Company by resignation of M/s. G.V.Rao & Co., the then existing Statutory Auditor.
  12. Mar 2011

  13. Feb 2011